ApoE, ApoE Receptors & Neurodegeneration, 2011
Chicago: 2nd Annual Symposium Explores ApoE ApoE, ApoE Receptors & Neurodegeneration, 2011
6390 RESULTS
Sort By:
Chicago: 2nd Annual Symposium Explores ApoE ApoE, ApoE Receptors & Neurodegeneration, 2011
Bapineuzumab Phase 3: Target Engagement, But No Benefit European Federation of Neurological Societies
Beijing: Report From Symposium on Aging and Neurodegeneration Beijing Symposium on Aging and Neurodegeneration
Paris: Synaptic Plasticity and the Mechanism of Alzheimer Disease Ipsen Colloquium on Alzheimer’s Disease 2007
Paris: Intracellular Traffic and Neurodegenerative Disorders Ipsen Colloquium on Alzheimer’s Disease 2008
Paris: Epigenetics, Brain, and Behavior Ipsen Neuroscience Colloquium 2011
Paris: Diabetes, Insulin, and Alzheimer Disease Ipsen Colloquium on Alzheimer’s Disease 2009
Paris: Macro-roles for MicroRNAs in the Life and Death of Neurons Ipsen Neuroscience Colloquium 2009
Bill Klunk Reports from Paris on The Living Brain and Alzheimer’s Disease Ipsen Colloquium on Alzheimer’s Disease 2003
Challenging Views of Alzheimer's Disease: Meeting Notes Challenging Views of Alzheimer's Disease
Conference Coverage: IPSEN Foundation Ipsen Colloquium on Immunization against Alzheimer's and Other Neurodegenerative Diseases 2002
Conference Report "Cell and Molecular Biology of Alzheimer's Disease" Cell and Molecular Biology of Alzheimer's Disease
DIAN Trial Picks Gantenerumab, Solanezumab, Maybe BACE Inhibitor Expanding the Network, DIAN Starts Showing Longitudinal Data Data in Disguise: As Results Roll In, DIAN Works to Guard Privacy Families Fight Back As Disease Claws at Next Generation Thought
Dave Holtzman Reports on Cerebral Amyloid Angiopathy from England International CAA Conference 2002
End of the Road for GDNF Parkinson Therapy—or Just a Detour? American Neurological Association: 2004 Annual Meeting
No filters selected